Company: MYGN
Filing Date: 2025-05-01
Form Type: S-8
Source: 0000899923-25-000037
Chunk: 1

Company: MYRIAD GENETICS INC
Filing Date: 2025-05-01
Form: S-8
Chunk 1
---
 new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [ ]

### EXPLANATORY NOTE
This Registration Statement registers an aggregate of 506,072 shares of common stock, par value $0.01 per share of Myriad Genetics, Inc. (the “Registrant”), consisting of (i) 269,905 shares issuable upon the vesting of restricted stock units granted to a new employee pursuant to a Restricted Stock Unit Agreement dated as of May 1, 2025 by and between the Registrant and the new employee, and (ii) 236,167 shares issuable upon the vesting of performance-based restricted stock units granted to the new employee pursuant to a Performance-Based Restricted Stock Unit Agreement dated as of May 1, 2025 by and between the Registrant and the new employee, in each case, in accordance with Nasdaq Listing Rule 5635(c)(4) as an inducement material to the new employee entering into employment with the Registrant.

# PART I
<div align='center'>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>

The documents containing the information specified in “Item 1. Plan Information” and “Item 2. Registrant Information and Employee Plan Annual Information” of Form S-8, have been or will be delivered to the participant in accordance with Form S-8 and Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

# PART II

### INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.

The following documents filed by the Registrant with the Commission are incorporated herein by reference:

(a) our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Commission on February 28, 2025;

(b) our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 9, 2025 (excluding those portions that are not incorporated by reference into our Annual Report on Form 10-K for the fiscal year ended December 31, 2024); and

(c